한글목차

의약품 위탁 개발 및 제조 기업(CMO) 시장 규모는 최근 급성장하고 있습니다. 2025년 547억 3,000만 달러에서 2026년에는 607억 달러에 이르고, CAGR 10.9%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 제약기업의 연구개발비 증가, 만성질환 유병률 증가, 제네릭 의약품 수요 증가, 의약품 제조기술의 발전, 전임상 및 임상연구에 대한 관심 증가 등이 주요 요인으로 작용한 것으로 분석됩니다.

의약품 위탁 개발 및 제조 기업 기관(CMO) 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 907억 6,000만 달러에 이르고, CAGR은 10.6%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 개인 맞춤형 의료의 도입 확대, 생물학적 제제 및 복합 치료제에 대한 수요 증가, 신흥 시장에서의 CDMO 역량 확대, 의약품 개발에 대한 디지털 기술 통합, 제약업계의 전략적 제휴 및 합병 증가 등을 꼽을 수 있습니다. 주요 동향으로는 의약품 개발 및 제조 아웃소싱, CDMO 서비스 포트폴리오 확대, 규제 준수 및 품질 보증에 대한 집중, 제약사와 CDMO 간의 전략적 제휴, 고급 분석 및 시험 서비스 도입 등이 예상됩니다.

특허만료 증가율은 의약품 위탁개발생산(CDMO) 시장의 성장을 가속할 것으로 예측됩니다. 특허 만료는 발명자 또는 특허권자에게 부여된 법적 보호의 독점적 권리의 종료를 의미하며, 경쟁사가 오리지널 제품의 제네릭 버전을 제조 및 판매할 수 있도록 허용합니다. CDMO는 특허 만료 후 제네릭 의약품을 신속하게 개발, 제조하여 시장에 출시할 수 있도록 하는 데 중요한 역할을 합니다. 예를 들어, 중국에 본사를 둔 제약 및 생명공학 산업 분석 회사인 DrugTimes에 따르면, 2024년 2월 기준, 2037년까지 25개 이상의 제품이 특허 보호를 잃을 것으로 예상되며, 2024년 매출을 기준으로 총 2,364억 달러 이상의 매출 감소가 발생할 가능성이 있습니다. 따라서 특허 만료 증가는 CDMO 서비스에 대한 수요를 촉진하고 있습니다.

제약 CDMO 시장의 주요 기업들은 DevPack과 같은 통합 솔루션 개발 등 진화하는 업계 요구에 대응하기 위해 서비스 제공 범위를 확장하고 있습니다. DevPack은 여러 파트너사 간에 최적화된 서비스로, 개발 프로세스 단계의 표준화된 데이터 세트를 생성하여 연구개발과 제조의 효율화를 촉진합니다. 예를 들어, 2023년 5월 독일에 본사를 둔 위탁 연구개발 및 제조 서비스 제공업체인 ASM Research Chemicals는 의약품 유효성분(API) 제조에 특화된 개발 팩 서비스인 'DevPack'을 출시했습니다. 10개의 주요 파트너사 간에 최적화된 DevPack은 개발 프로세스를 위한 표준화된 데이터 세트를 제공하고, API의 분석 개발, 규제 당국 신청, 초기 단계의 제조 경로 개발을 지원합니다. 이 서비스는 API 개발을 가속화하고자 하는 CMO와 제약회사에 특히 유용합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pharmaceutical contract development and manufacturing refers to businesses that provide drug research and production services within the pharmaceutical industry. By partnering with CDMOs, pharmaceutical companies can outsource the development and manufacturing of medications. Full-service CDMOs manage all stages of the process or collaborate with clients who wish to outsource specific steps, depending on each client's requirements.

The main types of pharmaceutical contract development and manufacturing organizations (CMOs) are contract manufacturing services and contract research services. Contract manufacturing services involve outsourcing production processes to a third-party company, known as a contract manufacturer. Research phases covered include preclinical, Phase I, Phase II, Phase III, and Phase IV. The end-use sectors include large pharmaceutical companies, generic pharmaceutical companies, and small to medium-sized pharmaceutical companies.

Tariffs have influenced the pharmaceutical contract development and manufacturing market by increasing the cost of imported raw materials, active pharmaceutical ingredients (APIs), and specialized equipment, which has raised overall production costs. This impact is most pronounced in segments such as API manufacturing and formulation development, particularly in regions like Asia-Pacific and Europe that serve as key suppliers. While tariffs have posed challenges by slowing project timelines, they have also encouraged local sourcing, regional manufacturing investments, and innovation in cost-efficient production processes, ultimately creating strategic opportunities for CDMOs to optimize supply chains.

The pharmaceutical contract development and manufacturing organization (cmo) market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing organization (cmo) market statistics, including pharmaceutical contract development and manufacturing organization (cmo) industry global market size, regional shares, competitors with a pharmaceutical contract development and manufacturing organization (cmo) market share, detailed pharmaceutical contract development and manufacturing organization (cmo) market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing organization (cmo) industry. This pharmaceutical contract development and manufacturing organization (cmo) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical contract development and manufacturing organization (cmo) market size has grown rapidly in recent years. It will grow from $54.73 billion in 2025 to $60.7 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing r&d expenditures by pharmaceutical companies, rising prevalence of chronic diseases, growth in generic drug demand, technological advancements in drug manufacturing, increasing focus on preclinical and clinical research.

The pharmaceutical contract development and manufacturing organization (cmo) market size is expected to see rapid growth in the next few years. It will grow to $90.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising adoption of personalized medicine, growing demand for biologics and complex therapeutics, expansion of cdmo capabilities in emerging markets, integration of digital technologies in drug development, increasing strategic partnerships and mergers in pharmaceutical sector. Major trends in the forecast period include outsourcing of drug development and manufacturing, expansion of cdmo service portfolios, regulatory compliance and quality assurance focus, strategic partnerships between pharma companies and cdmos, adoption of advanced analytical and testing services.

The increasing rate of patent expirations is expected to drive growth in the pharmaceutical contract development and manufacturing (CDMO) market. Patent expiration marks the end of the legally protected exclusive rights granted to an inventor or patent holder, allowing competitors to produce and sell generic versions of the original product. CDMOs play a critical role in enabling the rapid development and manufacturing of generic drugs to enter the market following patent expiry. For instance, in February 2024, according to DrugTimes, a China-based pharmaceutical and biotech industry analytics firm, over 25 products are projected to lose patent protection by 2037, potentially resulting in a combined revenue decline exceeding $236.4 billion based on 2024 sales. Therefore, the rising incidence of patent expirations is fueling demand for CDMO services.

Key companies in the pharmaceutical CDMO market are expanding their service offerings to meet evolving industry needs, such as through the development of integrated solutions like the DevPack. The DevPack is a service optimized across multiple partners to create a standardized dataset of development process steps, facilitating streamlined research and manufacturing. For instance, in May 2023, ASM Research Chemicals, a Germany-based provider of contract research and manufacturing services, launched DevPack, a development pack service tailored for active pharmaceutical ingredient (API) manufacturing. Optimized across ten core partners, DevPack provides a standardized dataset for development processes, supporting analytical development, regulatory submissions, and early-stage manufacturing route development for APIs. This service is particularly beneficial for CMOs and pharmaceutical companies aiming for accelerated API development.

In December 2023, Ajinomoto Group, a Japan-based global food and biotechnology company, acquired Forge Biologics Inc. for an undisclosed amount. Through this acquisition, Ajinomoto Group aims to expand its gene therapy CDMO capabilities, strengthen its global biopharmaceutical manufacturing footprint, and enhance its portfolio in advanced therapeutics. Forge Biologics Inc., a US-based CDMO, specializes in AAV-based gene therapy solutions.

Major companies operating in the pharmaceutical contract development and manufacturing organization (cmo) market are Lonza Group, Catalent Inc, WuXi AppTec Inc., Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co. Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, Eurofarma Laboratorios S.A., Ache Laboratorios Farmaceuticos S.A., Blanver Farmoquimica e Farmaceutica S.A., Prati-Donaduzzi, Uniao Quimica Farmaceutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals

North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical contract development and manufacturing market includes revenues earned by entities by providing drug development and manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical contract development and manufacturing organization (cmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (cmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical contract development and manufacturing organization (cmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Contract Manufacturing Services; Contract Research Services
• 2) By Research Phase: Preclinical; Phase I; Phase II; Phase III; Phase IV
• 3) By End User: Big Pharmaceutical Companies; Generic Pharmaceutical Companies; Small And Medium-Sized Pharmaceutical Companies
• Subsegments:
• 1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing; Formulation Development; Finished Dosage Form Manufacturing; Packaging Services; Supply Chain Management
• 2) By Contract Research Services: Preclinical Research Services; Clinical Trial Management; Regulatory Affairs Consulting; Biostatistics And Data Management; Analytical And Testing Services
• Companies Mentioned: Lonza Group; Catalent Inc; WuXi AppTec Inc.; Recipharm AB; Almac Group; Aenova Group; Baxter International Inc; SGS Life Science Services SA; Jubilant Pharmova Ltd; Dishman Pharmaceuticals; Kemwell Pvt. Ltd.; Nipro Corp.; CMIC Group; Sawai Pharmaceutical Co. Ltd; IDT Australia Limited; Aurigene Pharmaceutical Services Limited; Vetter Pharma International GMBH; Consort Medical PLC; Siegfried Holding AG; Evonik Industries; NextPharma; Royal DSM N.V; HAUPT Pharma AG; Famar; OTC-PharmNEUCA; Farmacol; Polska Grupa Farmaceutyczna; Polpharma; TZMO; Eurofarma Laboratorios S.A.; Ache Laboratorios Farmaceuticos S.A.; Blanver Farmoquimica e Farmaceutica S.A.; Prati-Donaduzzi; Uniao Quimica Farmaceutica Nacional S.A; Laboratorios Richmond S.A.C.I.F.; Bago S.A.; Elea Laboratories S.A.C.I. y F.; Gador S.A.; LIFEPharma; Neopharm; Gulf Pharmaceutical Industries JULPHA; NewBridge Pharmaceuticals Limited; Aspen Pharmacare Holdings Limited; Adcock Ingram Holdings Limited; Pharma-Q (Pty) Ltd; Vital Health Foods; EIPICO (Egyptian International Pharmaceutical Industries Company); Pharco Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Outsourcing Of Drug Development And Manufacturing
  • 4.2.2 Expansion Of Cdmo Service Portfolios
  • 4.2.3 Regulatory Compliance And Quality Assurance Focus
  • 4.2.4 Strategic Partnerships Between Pharma Companies And Cdmos
  • 4.2.5 Adoption Of Advanced Analytical And Testing Services

5. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Analysis Of End Use Industries

• 5.1 Big Pharmaceutical Companies
• 5.2 Generic Pharmaceutical Companies
• 5.3 Small Pharmaceutical Companies
• 5.4 Biotech Firms
• 5.5 Contract Research Organizations (Cros)

6. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

• 9.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Contract Manufacturing Services, Contract Research Services
• 9.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preclinical, Phase I, Phase II, Phase III, Phase IV
• 9.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
• 9.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Manufacturing Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
• 9.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Sub-Segmentation Of Contract Research Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services

10. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regional And Country Analysis

• 10.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 11.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 12.1. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 13.1. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 14.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 15.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 16.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 17.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 18.1. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 19.1. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 20.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 21.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 22.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 23.1. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 24.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 25.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 26.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 27.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 28.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 29.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 30.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 31.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 32.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 33.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

• 34.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Segmentation By Research Phase, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regulatory and Investment Landscape

36. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Company Profiles

• 36.1. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Company Profiles
  • 36.3.1. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. WuXi AppTec Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Recipharm AB Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Almac Group Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Other Major And Innovative Companies

• Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co. Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries

38. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

40. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market High Potential Countries, Segments and Strategies

• 40.1 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer